Search results
Emergent (EBS) Initiates Study on Lassa Virus Vaccine Candidate
Zacks via Yahoo Finance· 2 years agoEmergent BioSolutions EBS announced the dosing of the first patient in a phase I study evaluating...
Undervalued Biotech Stocks Shine: Pfizer and BioNTech Show Resilience
GuruFocus.com via Yahoo Finance· 7 months agoIn the ever-evolving world of the stock market, uncovering potential gold mines is paramount for...
3 Reasons to Buy Novavax and 1 to Sell
Motley Fool· 2 years agoNovavax (NASDAQ: NVAX) is a pandemic stock. Now it's down to $50, and the company's market cap is under $4 billion. Here are three arguments for buying...
2 “Strong Buy” Penny Stocks That Could See Huge Long-Term Gains
TipRanks via Yahoo Finance· 2 years agoThe first half of 2022 was marked by concerns over inflation, rising interest rates and recession,...
Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious...
Benzinga via Yahoo Finance· 1 year agoInovio Pharmaceuticals Inc (NASDAQ: INO) has agreed with its collaborator, the Coalition for...
Moderna (MRNA) Starts Early-Stage Nipah Virus Vaccine Study
Zacks via Yahoo Finance· 2 years agoModerna (MRNA) doses the first participant in the phase I study of its investigational mRNA vaccine,...
Novavax (NVAX) Cancels COVID Jab Supply Deal With GAVI
Zacks via Yahoo Finance· 1 year agoNovavax (NVAX) claims that GAVI's failure to procure its COVID vaccine doses is a reason to...
The Rise and Fall of Novavax
Motley Fool· 2 years agoNovavax (NASDAQ: NVAX) is one of my favorite stocks. Sometimes you'll hear the advice, "Don't fall in love with your stocks." I used to believe that, but...
FOCUS-Vaccine makers prep bird flu shot for humans 'just in case'; rich nations lock in supplies
Reuters via Yahoo Finance· 1 year agoSome of the world's leading makers of flu vaccines say they could make hundreds of millions of bird flu shots for humans within months if a new strain of avian influenza ever jumps across the ...
